Depakote and Drisdol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Depakote (divalproex sodium) and Drisdol (ergocalciferol). Common drug interactions include overweight among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Depakote and Drisdol. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Depakote?

Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,741 Drisdol users. Check the latest studies of Drisdol.



On Aug, 08, 2026

33 people who take Depakote and Drisdol together, and have interactions are studied.

Depakote and Drisdol drug interactions.

What are the common drug interactions of Depakote and Drisdol, by gender? *:

female:

  1. Overweight
  2. Pallor
  3. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Thirst
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Back pain
  10. Gait disturbance

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Platelet count decreased
  3. Blood calcium decreased
  4. Blood creatine decreased
  5. Blood glucose increased
  6. Blood thyroid stimulating hormone increased
  7. Body temperature decreased
  8. Carbon dioxide increased
  9. Confusional state
  10. Depression

What are the common drug interactions of Depakote and Drisdol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Appetite disorder (abnormal eating habits)
  2. Dysgeusia (disorder of the sense of taste)
  3. Nausea (feeling of having an urge to vomit)
  4. Neuropathy peripheral (surface nerve damage)
  5. Platelet count decreased
  6. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  7. Ageusia (loss of taste functions of the tongue)
  8. Colitis (inflammation of colon)
  9. Decreased appetite
  10. Malaise (a feeling of general discomfort or uneasiness)

40-49:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Activated partial thromboplastin time prolonged
  3. Alanine aminotransferase increased
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anion gap decreased
  6. Asthenia (weakness)
  7. Balance disorder
  8. Blood albumin decreased
  9. Blood alkaline phosphatase decreased
  10. Blood calcium decreased

50-59:

  1. Dizziness
  2. Feeling hot
  3. Hyperhidrosis (abnormally increased sweating)
  4. Nausea (feeling of having an urge to vomit)
  5. Pallor
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Thirst
  8. Blood pressure immeasurable
  9. Bradycardia (abnormally slow heart action)
  10. Cold sweat

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Death
  3. Fall
  4. Haemorrhage intracranial (bleeding within the skull)
  5. Insomnia (sleeplessness)
  6. Loss of consciousness
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

  1. Constipation: 13 people, 39.39%
  2. Stress And Anxiety: 11 people, 33.33%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 24.24%
  4. Depression: 8 people, 24.24%
  5. Pain: 7 people, 21.21%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 21.21%
  7. Nausea (feeling of having an urge to vomit): 6 people, 18.18%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 18.18%
  9. Fever: 5 people, 15.15%
  10. Wheezing (a high-pitched whistling sound made while you breath): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Depakote and Drisdol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Depakote and Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Depakote:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depakote and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Drisdol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium and ergocalciferol (the active ingredients of Depakote and Drisdol, respectively), and Depakote and Drisdol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: